These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 25684518)
1. Exogenous p53 upregulated modulator of apoptosis (PUMA) decreases growth of lung cancer A549 cells. Liu CJ; Zhang XL; Luo DY; Zhu WF; Wan HF; Yang JP; Yang XJ; Wan FS Asian Pac J Cancer Prev; 2015; 16(2):741-6. PubMed ID: 25684518 [TBL] [Abstract][Full Text] [Related]
2. Effect of diallyl trisulfide on human ovarian cancer SKOV- 3/DDP cell apoptosis. Wan HF; Yu LH; Wu JL; Tu S; Zhu WF; Zhang XL; Wan FS Asian Pac J Cancer Prev; 2013; 14(12):7197-201. PubMed ID: 24460275 [TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
4. SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis. Wang Y; Yue B; Yu X; Wang Z; Wang M World J Surg Oncol; 2013 Jan; 11():12. PubMed ID: 23339680 [TBL] [Abstract][Full Text] [Related]
5. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460 [TBL] [Abstract][Full Text] [Related]
6. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells. Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854 [TBL] [Abstract][Full Text] [Related]
7. [Effects of shRNA on Cisplatin-resistant Non-small Cell Lung Cancer Cell A549 via Silencing He L; Du ZD; Wang Y; Meng RQ; Zhao WW Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):312-319. PubMed ID: 32543135 [TBL] [Abstract][Full Text] [Related]
8. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213 [TBL] [Abstract][Full Text] [Related]
9. [Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer]. Gao ZQ; Han BH; Sha HF; Shi ZY; Yang XH; Feng JX Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):284-8. PubMed ID: 20646461 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998 [TBL] [Abstract][Full Text] [Related]
12. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Zhou W; Wang J; Man WY; Zhang QW; Xu WG Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776 [TBL] [Abstract][Full Text] [Related]
13. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
14. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells. Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131 [TBL] [Abstract][Full Text] [Related]
15. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway. Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125 [TBL] [Abstract][Full Text] [Related]
16. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo]. Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803 [TBL] [Abstract][Full Text] [Related]
17. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell]. Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910 [No Abstract] [Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
19. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
20. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice]. Dai M; Luo RC; Zheng DY; Lü CW; Ding XM Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]